Newsletter

Stay up to date on all things colon cancer. Sign up and we’ll send you the latest news, resources, scientific breakthroughs, events, tips, and much more.

Participatory Research to Advance Colon Cancer Prevention

November 21, 2019

Overview

The goal of this study is to test strategies to raise rates of colorectal cancer screening among the Latino population. This study will be split into two phases; the first will be using a community-based participatory research approach called boot camp translation (BCT). During this phase, BCT will be tailored and defined. In Phase II, the adapted BCT will be spread and tested in clinics within the partnering health center.

 

Study Information

This clinical trial will have an estimated enrollment of 15,000 participants and will be guided by an advisory group of clinicians, researchers, policy makers, and patients. It began on September 5th 2017 and is predicted to be completed by July 31st 2020.

 

Inclusion Criteria

 

Persons aged 50-75 years and not up-to-date with colorectal cancer screening

 

Exclusion Criteria

 

Persons having colorectal disease (e.g., ulcerative colitis or colectomy), personal history of colorectal cancer or colorectal disease, end-stage or life threatening diseases or, those known to be under hospice care or living in a skilled nursing facility may be excluded.

 

Location

This study is taking place at AltaMed Health Services, Los Angeles, California, United States, 90040. For further information please contact Jamie Thompson, MPH on 503-335-6335 or at jamie.h.thompson@kpchr.org.

 

Sponsors/Collaborators

This study is sponsored by Kaiser Permanente, Oregon Health and Science University and AltaMed Health Services. The Principal Investigator is Gloria Coronado, PhD of Kaiser Permanente.

Clinical Trials

View All Clinical Trials

DC Vaccine in Colorectal Cancer

This study is assessing the safety, tolerability and immune response rate the of mDC3 vaccine in patients with colorectal cancer.

Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk

This diet-intervention trial focuses on African American subjects who are at higher risk for developing colorectal cancer (CRC). Two diets, one…

Green Tea and Milk Thistle to Colorectal Cancer Patients

Colorectal cancer is the third most common form of cancer found in the United States, and surgical resection (removal) provides the best chance for…

Reducing Rural Colon Cancer Disparities

This study is exploring the difference in outcomes for cancer patients in rural vs. urban areas. Southern Illinois will be used as the prime…

Young-Onset Microsatellite-Stable Colorectal Cancer

The goal of this laboratory research study is to learn more about genetic factors that may influence the risk for developing colorectal cancer at a…

PalloV-CC in Colon Cancer

This study is looking at the effects of the PalloV CC vaccination on patients with colon cancer. The primary goals are to understand the safety of…

Exercise And Colon Cancer Treatment

This study is looking at how exercise may prevent the recurrence of colon cancer in patients who have completed their treatment. The primary…

Niclosamide in Patients With Resectable Colon Cancer

This study is examining the safety of the drug Niclosamide in patients with colon cancer that are undergoing primary resection (cutting out) of…

Make a comment and share this article on your profile.

Write a comment for your publication

Successfully Shared!

View on my Profile

Send this to a friend